Jul 16 |
Profound Medical upgraded at Stifel on Medicare policy update
|
Jul 11 |
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
|
Jun 14 |
Profound Medical files $150M mixed securities shelf
|
Jun 7 |
Insider Stock Buying Reaches US$781.1k On Profound Medical
|
May 15 |
Profound Medical Annual General Meeting of Shareholders Voting Results
|
May 14 |
Profound Medical gets FDA okay for TULSA AI module
|
May 14 |
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
|
May 11 |
Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript
|
May 11 |
Profound Medical First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
May 9 |
Profound Medical GAAP EPS of $0.26 beats by $0.57, revenue of $1.91M misses by $0.59M
|